Skip Navigation


American Journal of Epidemiology Advance Access originally published online on March 6, 2008
American Journal of Epidemiology 2008 167(7):888; doi:10.1093/aje/kwn048
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
167/7/888    most recent
kwn048v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology © The Author 2008. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

RE: "PHARMACOGENETIC MODULATION OF COMBINED HORMONE REPLACEMENT THERAPY BY PROGESTERONE-METABOLISM GENOTYPES IN POSTMENOPAUSAL BREAST CANCER RISK"

An error has been discovered in table 2 of the paper by Rebbeck et al. (1). The originally published table contains repetitious data that were inadvertently sent to the Journal after peer review and acceptance. The corrected results for this table are shown below; the remainder of the table is correct as originally published. The authors and the Journal regret this error.


View this table:
[in this window]
[in a new window]

  		TABLE 2. Adjusted* odds ratios for progesterone/progestin metabolism genotypes by duration of combined estrogen and progestin hormone replacement therapy, stratified by tumor histology in postmenopausal Caucasian women, Women's Insights and Shared Experiences Study, 1999–2002

 

References

  1. Rebbeck TR, Troxel AB, Norman S, et al. Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk. Am J Epidemiol (2007) 166:1392–9.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
167/7/888    most recent
kwn048v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?